This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $9,374.36 firm fixed-price contract was awarded on December 18, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of January 10, 2025. The contract is a delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Generated 3/19/25, 9:47 AM